Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321411![]() (6-[(E)-but-2-enyl]-4-[3-methoxy-4-(morpholine-4-ca...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321430![]() (6-[(E)-but-2-enyl]-4-[3-isopropoxy-4-(morpholine-4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321429![]() ((E)-1-(4-(6-(but-2-en-1-yl)-2-methyl-7-oxo-6,7-dih...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321438![]() (3-[6-[(E)-but-2-enyl]-2-methyl-7-oxo-1H-pyrrolo[2,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321432![]() ((E)-6-(but-2-en-1-yl)-4-(3-chloro-4-(piperazine-1-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321424![]() (6-[(E)-but-2-enyl]-4-[2,5-dimethoxy-4-(morpholine-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321433![]() ((E)-4-(4-(3-(3-amino-1H-pyrazol-1-yl)azetidine-1-c...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321412![]() (6-[(E)-but-2-enyl]-4-[3-chloro-4-(morpholine-4-car...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321431![]() (6-[(E)-but-2-enyl]-4-[3-(cyclopropylmethoxy)-4-(mo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321422![]() (5-[6-[(E)-but-2-enyl]-2-methyl-7-oxo-1H-pyrrolo[2,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321425![]() (3-[6-[(E)-but-2-enyl]-2-methyl-7-oxo-1H-pyrrolo[2,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321437![]() ((E)-6-(but-2-en-1-yl)-4-(4-(2-hydroxypropan-2-yl)-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 6 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321428![]() (1-[4-[6-[(E)-but-2-enyl]-2-methyl-7-oxo-1H-pyrrolo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321414![]() (6-[(E)-but-2-enyl]-4-[3-chloro-4-(4-methylpiperazi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321418![]() (6-allyl-4-[2,5-dimethoxy-4-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321436![]() (4-[4-[3-(3-aminopyrazol-1-yl)azetidine-1-carbonyl]...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321463![]() (6-(but-3-en-1-yl)-4-(3-(difluoromethoxy)-5-(morpho...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321409![]() (6-[(E)-but-2-enyl]-4-[3-chloro-4-(pyrrolidine-1-ca...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321470![]() (6-but-3-enyl-4-[1-methyl-6-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321465![]() (6-but-3-enyl-4-[3-methyl-7-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321476![]() (6-but-3-enyl-4-[4-fluoro-3-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321415![]() (6-[(E)-but-2-enyl]-2-methyl-4-[3-methyl-4-(morphol...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321465![]() (6-but-3-enyl-4-[3-methyl-7-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321462![]() (6-but-3-enyl-4-[4-fluoro-3-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321417![]() (6-allyl-4-[3-chloro-4-(morpholine-4-carbonyl)pheny...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321474![]() (6-but-3-enyl-4-[4-chloro-3-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321468![]() (6-but-3-enyl-4-[6-(morpholine-4-carbonyl)-1H-benzi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321389![]() (6-[(E)-but-2-enyl]-4-[3-chloro-4-(morpholine-4-car...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321407![]() (6-[(E)-but-2-enyl]-2-methyl-4-[4-(morpholine-4-car...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321383![]() (6-but-2-enyl-4-[4-(morpholine-4-carbonyl)phenyl]-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321408![]() (6-[(E)-but-2-enyl]-2-methyl-4-[4-(pyrrolidine-1-ca...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321467![]() (6-but-3-enyl-4-[3-ethyl-7-(morpholine-4-carbonyl)b...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321475![]() (6-but-3-enyl-4-[3-fluoro-5-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321402![]() (6-[(E)-but-2-enyl]-4-[4-(1-hydroxy-1-methyl-ethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321458![]() (6-but-3-enyl-4-[3,4-difluoro-5-(morpholine-4-carbo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321439![]() (6-butyl-4-[2,5-dimethoxy-4-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321459![]() (6-but-3-enyl-4-[3-fluoro-5-(3-methylmorpholine-4-c...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321469![]() (4-(6-(but-3-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321400![]() (6-[(E)-but-2-enyl]-4-[4-(1-hydroxy-1-methyl-ethyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321461![]() (6-but-3-enyl-4-[3-fluoro-5-(morpholine-4-carbonyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321460![]() (3-(6-but-3-enyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Chromatin remodeling regulator CECR2 [424-538] (Homo sapiens (Human)) | BDBM321464![]() (6-but-3-enyl-4-[7-(morpholine-4-carbonyl)-3H-benzi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 21 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged TAF1-BD21504-1635 was cloned, expressed, and purified to homogeneity. TAF1-BD2 binding and inhibition was assessed by monitor... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321381![]() (N-[4-(6-but-2-enyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321420![]() (6-[(E)-but-2-enyl]-4-[4-chloro-5-(morpholine-4-car...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321396![]() (3-[6-[(E)-but-2-enyl]-7-oxo-1H-pyrrolo[2,3-c]pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321398![]() (3-[6-[(E)-but-2-enyl]-7-oxo-1H-pyrrolo[2,3-c]pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321395![]() (3-[6-[(E)-but-2-enyl]-7-oxo-1H-pyrrolo[2,3-c]pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321392![]() (3-[6-[(E)-but-2-enyl]-7-oxo-1H-pyrrolo[2,3-c]pyrid...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321377![]() (4-(6-but-2-enyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-y...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Bromodomain-containing protein 9 [134-239] (Homo sapiens (Human)) | BDBM321413![]() (6-[(E)-but-2-enyl]-4-[5-chloro-6-(morpholine-4-car...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | n/a | n/a |
GENENTECH, INC.; CONSTELLATION PHARMACEUTICALS, INC. US Patent | Assay Description His/Flag epitope tagged BRD9134-239 was cloned, expressed, and purified to homogeneity. BRD9 binding and inhibition was assessed by monitoring the en... | US Patent US10183009 (2019) BindingDB Entry DOI: 10.7270/Q2125VRQ | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 122 total ) | Next | Last >> |